American Lithium Corp. (CVE:LI – Get Free Report) Director Claudia Tornquist sold 30,000 shares of the company’s stock in a transaction dated Monday, September 23rd. The stock was sold at an average price of C$0.50, for a total transaction of C$15,000.00.
Claudia Tornquist also recently made the following trade(s):
- On Friday, September 20th, Claudia Tornquist sold 30,000 shares of American Lithium stock. The shares were sold at an average price of C$0.50, for a total transaction of C$15,000.00.
American Lithium Price Performance
LI stock opened at C$0.56 on Wednesday. The business has a 50 day moving average price of C$0.57 and a 200 day moving average price of C$0.77. The stock has a market cap of C$121.83 million, a price-to-earnings ratio of -3.29 and a beta of 2.22. American Lithium Corp. has a fifty-two week low of C$0.44 and a fifty-two week high of C$1.99. The company has a quick ratio of 1.45, a current ratio of 5.35 and a debt-to-equity ratio of 0.07.
Wall Street Analysts Forecast Growth
Several equities analysts recently weighed in on LI shares. National Bankshares set a C$1.50 price target on shares of American Lithium and gave the stock an “outperform” rating in a report on Thursday, June 6th. National Bank Financial upgraded American Lithium to a “strong-buy” rating in a report on Thursday, June 6th.
View Our Latest Stock Report on American Lithium
American Lithium Company Profile
American Lithium Corp., an exploration and development stage company, engages in the acquisition, exploration, and development of resource properties in the United States. It principally focuses on the TLC Lithium Project located in the town of Tonopah, Nevada; and the Falchani Lithium project and the Macusani Uranium project located in Puno, Peru.
See Also
- Five stocks we like better than American Lithium
- 3 Stocks to Consider Buying in October
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Best Stocks Under $10.00
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Technology Stocks Explained: Here’s What to Know About Tech
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for American Lithium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Lithium and related companies with MarketBeat.com's FREE daily email newsletter.